We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease

By LabMedica International staff writers
Posted on 08 Jul 2025

Senescent cells, which stop growing and reproducing due to injury, aging, or disease, play a critical role in wound repair and aging-related diseases like cancer and heart disease. More...

These cells, however, contribute to tissue degeneration over time, and tracking them can provide valuable insights into how tissues lose their regenerative capabilities and how these cells fuel disease progression. Existing methods for detecting and analyzing senescent cells are difficult to use and lack the precision required for real-time monitoring in living cells. To address this gap, researchers have developed a tool that uses artificial intelligence (AI) and high-resolution imaging to track senescent cells, providing a more accurate way to study their role in aging and disease.

The solution, called the Nuclear Morphometric Pipeline (NMP), was developed by researchers from NYU Langone Health (New York, NY, USA). The NMP uses AI analysis to examine changes in the physical characteristics of the nucleus, such as its shape and density, which correlate with the degree of cellular senescence. The tool was trained to analyze animal cells subjected to increasing chemical concentrations to replicate human aging. The researchers used this AI model to monitor the nucleus’s expanded shape, denser foci, and lighter genetic staining, which are indicative of senescent cells. The NMP produces a single score to quantify senescence across different cell types and stages of age.

The NMP was validated through testing on cells from young and older mice, including injured muscle tissue and cartilage cells. The NMP accurately tracked the presence of senescent cells and distinguished between healthy and diseased tissues, such as cartilage in geriatric mice with osteoarthritis. These results, published in Nature Communications, confirmed the tool’s effectiveness in distinguishing senescent cells in various tissues and ages. The NMP could be used to explore the role of senescence in aging, tissue repair, and disease. Researchers plan to apply the NMP to human tissues and combine it with other biomarkers to develop therapies targeting senescence and its detrimental effects.

“Our study demonstrates that specific nuclear morphometrics can serve as a reliable tool for identifying and tracking senescent cells, which we believe is key to future research and understanding of tissue regeneration, aging, and progressive disease,” said Dr. Michael Wosczyna, Assistant Professor, Department of Orthopedic Surgery, NYU Grossman School of Medicine.

Related Links:
NYU Langone Health


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.